RTBDN
gene geneOn this page
Also known as FLJ36353
Summary
RTBDN (retbindin, HGNC:30310) is a protein-coding gene on chromosome 19p13.13, encoding Retbindin (Q9BSG5). Riboflavin-binding protein which might have a role in retinal flavin transport.
This gene was first identified in a study of human eye tissues. The protein encoded by this gene is preferentially expressed in the retina and may play a role in binding retinoids and other carotenoids as it shares homology with riboflavin binding proteins. Alternative splicing results in multiple transcript variants and protein isoforms.
Source: NCBI Gene 83546 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 35 total
- MANE Select transcript:
NM_001270441
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30310 |
| Approved symbol | RTBDN |
| Name | retbindin |
| Location | 19p13.13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ36353 |
| Ensembl gene | ENSG00000132026 |
| Ensembl biotype | protein_coding |
| OMIM | 609553 |
| Entrez | 83546 |
Gene structure
Transcript identifiers
Ensembl transcripts: 27 — 27 protein_coding
ENST00000322912, ENST00000393233, ENST00000458671, ENST00000585384, ENST00000586969, ENST00000587549, ENST00000589272, ENST00000589567, ENST00000589681, ENST00000589808, ENST00000590404, ENST00000591512, ENST00000592204, ENST00000674343, ENST00000866320, ENST00000866321, ENST00000866322, ENST00000934867, ENST00000934868, ENST00000934869, ENST00000965056, ENST00000965057, ENST00000965058, ENST00000965059, ENST00000965060, ENST00000965061, ENST00000965062
RefSeq mRNA: 8 — MANE Select: NM_001270441
NM_001080997, NM_001270440, NM_001270441, NM_001270442, NM_001270443, NM_001270444, NM_001270445, NM_031429
CCDS: CCDS12283, CCDS45994, CCDS59356
Canonical transcript exons
ENST00000674343 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002854337 | 12825482 | 12825933 |
| ENSE00003729012 | 12828657 | 12828767 |
| ENSE00003732585 | 12826775 | 12826871 |
| ENSE00003735817 | 12828869 | 12828953 |
| ENSE00003748087 | 12829811 | 12829997 |
| ENSE00003898798 | 12834489 | 12834579 |
Expression profiles
Bgee: expression breadth ubiquitous, 107 present calls, max score 86.78.
FANTOM5 (CAGE): breadth broad, TPM avg 1.9237 / max 781.1282, expressed in 265 samples.
FANTOM5 promoters (12 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 179401 | 1.0971 | 69 |
| 179406 | 0.2226 | 87 |
| 179409 | 0.2055 | 110 |
| 179403 | 0.0844 | 9 |
| 179400 | 0.0760 | 8 |
| 179402 | 0.0756 | 10 |
| 179405 | 0.0508 | 30 |
| 179407 | 0.0436 | 25 |
| 179408 | 0.0337 | 11 |
| 179397 | 0.0173 | 5 |
Top tissues by expression
229 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| pituitary gland | UBERON:0000007 | 86.78 | gold quality |
| adenohypophysis | UBERON:0002196 | 86.76 | gold quality |
| prefrontal cortex | UBERON:0000451 | 82.09 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 80.79 | gold quality |
| right frontal lobe | UBERON:0002810 | 80.73 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 80.70 | gold quality |
| amygdala | UBERON:0001876 | 79.46 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 79.26 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 77.86 | gold quality |
| frontal cortex | UBERON:0001870 | 77.85 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 77.58 | gold quality |
| islet of Langerhans | UBERON:0000006 | 76.97 | gold quality |
| neocortex | UBERON:0001950 | 76.94 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 75.80 | gold quality |
| cerebral cortex | UBERON:0000956 | 75.07 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 74.61 | silver quality |
| hypothalamus | UBERON:0001898 | 73.49 | gold quality |
| temporal lobe | UBERON:0001871 | 72.58 | gold quality |
| Ammon’s horn | UBERON:0001954 | 72.25 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 71.11 | gold quality |
| cerebellar cortex | UBERON:0002129 | 71.07 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 71.07 | gold quality |
| forebrain | UBERON:0001890 | 70.27 | gold quality |
| brain | UBERON:0000955 | 69.29 | gold quality |
| cerebellum | UBERON:0002037 | 69.11 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 66.86 | gold quality |
| upper arm skin | UBERON:0004263 | 66.35 | gold quality |
| kidney epithelium | UBERON:0004819 | 65.83 | gold quality |
| entorhinal cortex | UBERON:0002728 | 65.22 | silver quality |
| epithelial cell of pancreas | CL:0000083 | 64.10 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7316 | yes | 59.58 |
| E-MTAB-6379 | no | 1.55 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
18 targeting RTBDN, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-1323 | 99.83 | 69.89 | 2471 |
| HSA-MIR-6756-5P | 99.82 | 67.97 | 2466 |
| HSA-MIR-548O-3P | 99.74 | 69.30 | 2228 |
| HSA-MIR-6766-5P | 99.68 | 67.70 | 2325 |
| HSA-MIR-5584-5P | 99.49 | 68.22 | 2814 |
| HSA-MIR-10399-5P | 99.17 | 69.87 | 2610 |
| HSA-MIR-6504-3P | 99.17 | 69.31 | 2891 |
| HSA-MIR-4254 | 99.11 | 65.15 | 1315 |
| HSA-MIR-6776-5P | 98.54 | 67.43 | 1304 |
| HSA-MIR-6873-5P | 98.45 | 66.14 | 1417 |
| HSA-MIR-490-3P | 97.79 | 65.54 | 606 |
| HSA-MIR-4314 | 97.50 | 67.30 | 1369 |
| HSA-MIR-5194 | 96.77 | 63.91 | 1021 |
| HSA-MIR-6738-5P | 96.33 | 63.61 | 815 |
| HSA-MIR-1914-3P | 95.07 | 63.37 | 762 |
Literature-anchored findings (GeneRIF, showing 2)
- retbindin is an excellent candidate for binding retinal flavins and possibly participating in their transport from the extracellular space to the photoreceptors. (PMID:25542898)
- Retbindin is capable of flavin binding. This characteristic can protect photoreceptors from flavin-sensitized light damage. Human retbindin in the culture media of a riboflavin-sensitized transgenic mouse cone cell line protected it from a 1-hour light-box exposure at 12,000 lux. (PMID:29721980)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | rtbdn | ENSDARG00000103413 |
| mus_musculus | Rtbdn | ENSMUSG00000048617 |
| rattus_norvegicus | Rtbdn | ENSRNOG00000043215 |
Paralogs (4): FOLR1 (ENSG00000110195), FOLR3 (ENSG00000110203), FOLR2 (ENSG00000165457), IZUMO1R (ENSG00000183560)
Protein
Protein identifiers
Retbindin — Q9BSG5 (reviewed: Q9BSG5)
All UniProt accessions (10): Q9BSG5, K7EIS2, K7EKV3, K7EM70, K7EN64, K7ENA4, K7EQL9, K7ES48, K7ESG0, K7ESL8
UniProt curated annotations — full annotation on UniProt →
Function. Riboflavin-binding protein which might have a role in retinal flavin transport.
Subcellular location. Secreted. Extracellular space. Extracellular matrix. Interphotoreceptor matrix. Cell membrane.
Tissue specificity. Expressed in peripheral retina (at protein level).
Post-translational modifications. Not N-glycosylated.
Similarity. Belongs to the folate receptor family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9BSG5-1 | 1 | yes |
| Q9BSG5-2 | 2 | |
| Q9BSG5-3 | 3 |
RefSeq proteins (8): NP_001074466, NP_001257369, NP_001257370, NP_001257371, NP_001257372, NP_001257373, NP_001257374, NP_113617 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR004269 | Folate_rcpt | Family |
| IPR018143 | Folate_rcpt-like | Domain |
Pfam: PF03024
UniProt features (11 total): disulfide bond 4, splice variant 2, signal peptide 1, chain 1, sequence variant 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BSG5-F1 | 66.17 | 0.16 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (4): 79–149, 86–126, 119–163, 132–145
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 77 (showing top):
RNGTGGGC_UNKNOWN, BENPORATH_ES_WITH_H3K27ME3, TGCGCANK_UNKNOWN, E2F4DP1_01, GOCC_CELL_SURFACE, E2F1DP1_01, E2F1DP2_01, GOBP_ORGANIC_ANION_TRANSPORT, GCM_DDX11, GOBP_VITAMIN_TRANSPORT, TGGNNNNNNKCCAR_UNKNOWN, GCM_NF2, MEF2_03, GOCC_SIDE_OF_MEMBRANE, chr19p13
GO Biological Process (1): riboflavin transport (GO:0032218)
GO Molecular Function (3): riboflavin transmembrane transporter activity (GO:0032217), signaling receptor activity (GO:0038023), riboflavin binding (GO:1902444)
GO Cellular Component (5): external side of plasma membrane (GO:0009897), interphotoreceptor matrix (GO:0033165), extracellular region (GO:0005576), plasma membrane (GO:0005886), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| vitamin transport | 1 |
| nitrogen compound transport | 1 |
| riboflavin transport | 1 |
| vitamin transmembrane transporter activity | 1 |
| molecular transducer activity | 1 |
| anion binding | 1 |
| heterocyclic compound binding | 1 |
| plasma membrane | 1 |
| cell surface | 1 |
| side of membrane | 1 |
| specialized extracellular matrix | 1 |
| membrane | 1 |
| cell periphery | 1 |
Protein interactions and networks
STRING
268 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RTBDN | OPTC | Q9UBM4 | 560 |
| RTBDN | ZNF256 | Q9Y2P7 | 541 |
| RTBDN | GUCY1A2 | P33402 | 503 |
| RTBDN | BEST2 | Q8NFU1 | 472 |
| RTBDN | GUCA2B | Q16661 | 460 |
| RTBDN | PRPH2 | P23942 | 428 |
| RTBDN | RAD18 | Q9NS91 | 423 |
| RTBDN | KCNB1 | Q14721 | 410 |
| RTBDN | TTC9B | Q8N6N2 | 401 |
| RTBDN | SLC24A1 | O60721 | 377 |
| RTBDN | FLAD1 | Q8NFF5 | 375 |
| RTBDN | RAD17 | O75943 | 371 |
| RTBDN | FANCL | Q9NW38 | 361 |
| RTBDN | ERICH1 | Q86X53 | 350 |
| RTBDN | PTGR3 | Q8N4Q0 | 348 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| RTBDN | COL6A1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (24): TSEN2 (Affinity Capture-MS), TTC19 (Affinity Capture-MS), UBAC1 (Affinity Capture-MS), ZER1 (Affinity Capture-MS), DDX19B (Affinity Capture-MS), BIRC6 (Affinity Capture-MS), GAS6 (Affinity Capture-MS), COL6A1 (Affinity Capture-MS), AMD1 (Affinity Capture-MS), GAS6 (Affinity Capture-MS), ZER1 (Affinity Capture-MS), TTC19 (Affinity Capture-MS), COL6A1 (Affinity Capture-MS), AMD1 (Affinity Capture-MS), UBAC1 (Affinity Capture-MS)
ESM2 similar proteins: A0A8M9PDM1, A0A8M9QN10, A1L3I3, A2AWH2, A2CI97, A2CI98, A4IFM1, A4IHZ3, A7E2V4, A7E305, B1AL88, B6CKP4, E7F211, F8W3R9, O55034, O94901, P35054, P51864, P86275, P98153, P98154, Q0VCT2, Q3UHH1, Q498C7, Q4KM46, Q4TUC0, Q58T08, Q5EB20, Q5HZE8, Q5RD34, Q5VUB5, Q6UW32, Q6V9Y8, Q7TNI2, Q7Z5A8, Q80ZA7, Q86VZ4, Q8CB67, Q8CCS2, Q8N0W7
Diamond homologs: Q4TUC0, Q5DRQ5, Q8QZY4, Q9BSG5, F1M928, Q9EQF4, P02752
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
35 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 28 |
| Likely benign | 1 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1201 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:12828773:C:CT | acceptor_gain | 1.0000 |
| 19:12828774:G:C | acceptor_gain | 1.0000 |
| 19:12828775:T:TC | acceptor_gain | 1.0000 |
| 19:12828863:A:AC | donor_gain | 1.0000 |
| 19:12828864:C:CC | donor_gain | 1.0000 |
| 19:12828865:TCA:T | donor_loss | 1.0000 |
| 19:12828866:CA:C | donor_loss | 1.0000 |
| 19:12828867:A:AC | donor_gain | 1.0000 |
| 19:12828867:ACTCA:A | donor_loss | 1.0000 |
| 19:12828868:C:CA | donor_gain | 1.0000 |
| 19:12828868:CT:C | donor_gain | 1.0000 |
| 19:12825930:AGGT:A | acceptor_gain | 0.9900 |
| 19:12825933:TCTAG:T | acceptor_loss | 0.9900 |
| 19:12825934:C:CC | acceptor_gain | 0.9900 |
| 19:12826772:CA:C | donor_loss | 0.9900 |
| 19:12826774:C:CG | donor_loss | 0.9900 |
| 19:12826870:ACCT:A | acceptor_loss | 0.9900 |
| 19:12826878:A:C | acceptor_gain | 0.9900 |
| 19:12826882:C:CT | acceptor_gain | 0.9900 |
| 19:12828652:CCTAC:C | donor_loss | 0.9900 |
| 19:12828653:CTAC:C | donor_loss | 0.9900 |
| 19:12828655:A:AC | donor_gain | 0.9900 |
| 19:12828655:ACCAG:A | donor_loss | 0.9900 |
| 19:12828656:C:CC | donor_gain | 0.9900 |
| 19:12828656:CCAGG:C | donor_gain | 0.9900 |
| 19:12828763:CGCAT:C | acceptor_gain | 0.9900 |
| 19:12828765:CAT:C | acceptor_gain | 0.9900 |
| 19:12828768:C:CA | acceptor_loss | 0.9900 |
| 19:12828768:C:CC | acceptor_gain | 0.9900 |
| 19:12828774:G:GC | acceptor_gain | 0.9900 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000163967 (19:12837150 T>A), RS1000568610 (19:12830590 C>T), RS1000667526 (19:12830941 CTGTG>C,CTG,CTGTGTG), RS1001122229 (19:12831213 T>A,C), RS1001158221 (19:12837125 G>A), RS1001232541 (19:12833283 G>A), RS1001242350 (19:12833683 A>C), RS1001961650 (19:12836568 A>G,T), RS1002083118 (19:12826749 C>T), RS1002165663 (19:12830596 G>A), RS1002241512 (19:12831758 T>C), RS1002249621 (19:12832123 C>G,T), RS1002837514 (19:12829346 C>A,T), RS1002855374 (19:12834783 A>G), RS1002917514 (19:12835513 G>A,T)
Disease associations
OMIM: gene MIM:609553 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000503_11 | Mean corpuscular volume | 2.000000e-12 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| ethyl-p-hydroxybenzoate | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Silicon Dioxide | decreases methylation | 1 |
| Valproic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.